Targeted Funding Opportunities

Targeted Funding Opportunity Announcements

• Technology Development for Single-Molecule Protein Sequencing (PA-21-247)
  This targeted funding opportunity seeks to fund technology development research efforts in instrumentation innovation and sample preparation/processing approaches for single-molecule protein sequencing.

• Notice of Special Interest (NOSI): National Cancer Institute SBIR/STTR Program Announcement Regarding Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (NOT-CA-21-062)
  The NCI encourages grant applications from small businesses to develop or adapt, apply, and validate existing or emerging technologies into user-friendly, low-resource setting-appropriate technologies for cancer prevention, diagnosis, or treatment

• Development of Highly Innovative Tools and Technology for Analysis of Single Cells (PA-20-047, PA-20-025)
  This targeted funding opportunity is for projects that focus on developing next-generation technologies and tools to better define cell heterogeneity and organization rules. The goal of the funding opportunity is to accelerate the development and translation of the cutting-edge single cell analysis approaches.

• Targeted Funding Opportunities for Commercializing Understudied Proteins (PA-19-034, PA-19-033)
  This Funding Opportunity Announcement aims to provide funding support for small businesses to initiate translational research of understudied proteins identified in the "Illuminating the Druggable Genome" project (IDG; https://commonfund.nih.gov/idg/index).

​

• Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (PA-18-801, PA-18-802)
  This targeted funding opportunity is for small businesses that are developing cancer technologies that can be used in low-resource settings, such as low- and middle-income countries and low-resource settings in the U.S. 
  - SBIR Direct-to-Phase II is now available for PA-18-801. More information available on Guide Notice NOT-CA-19-003.
  - Phase I Budget cap has increased to $400,000. More information available on Guide Notices NOT-CA-19-055 and NOT-CA-19-056. 

• SBIR Technology transfer (PA-18-705)
  SBIR only. Funding opportunity for small businesses interested in translating NCI-developed technology from lab to patients.

This page is updated as new funding opportunities are announced. Please visit this page often to view new opportunities. View the NIH SBIR/STTR website for more information on targeted funding opportunities.

You may also sign up to receive email updates from NCI SBIR & STTR Programs announcing new funding opportunities. If you would like to receive updates from the NCI SBIR & STTR Programs, please subscribe to our mailing list.